4/7
12:36 pm
amlx
Rating for AMLX
Low
Report
Rating for AMLX
4/7
12:36 pm
amlx
Rating for AMLX
Low
Report
Rating for AMLX
4/7
08:55 am
amlx
Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) was upgraded by analysts at Mizuho from a "neutral" rating to an "outperform" rating. They now have a $7.00 price target on the stock.
Medium
Report
Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) was upgraded by analysts at Mizuho from a "neutral" rating to an "outperform" rating. They now have a $7.00 price target on the stock.
4/7
08:55 am
amlx
Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) was upgraded by analysts at Mizuho from a "neutral" rating to an "outperform" rating. They now have a $7.00 price target on the stock.
Medium
Report
Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) was upgraded by analysts at Mizuho from a "neutral" rating to an "outperform" rating. They now have a $7.00 price target on the stock.
4/7
08:29 am
amlx
Amylyx upgraded to Outperform from Neutral at Mizuho
Low
Report
Amylyx upgraded to Outperform from Neutral at Mizuho
4/7
08:29 am
amlx
Amylyx upgraded to Outperform from Neutral at Mizuho
Low
Report
Amylyx upgraded to Outperform from Neutral at Mizuho
3/5
08:11 am
amlx
Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.
Medium
Report
Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.